Literature DB >> 28978983

Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism.

Kanako Bokuda1, Midori Yatabe1, Yuki Mizuguchi1, Michita Niiyama1, Yasufumi Seki1, Daisuke Watanabe1, Junichi Yatabe1, Takashi Ando1, Satoshi Morimoto1, Atsuhiro Ichihara1.   

Abstract

The effect of unilateral adrenalectomy on blood pressure (BP) outcome in primary aldosteronism (PA) is diverse. Therefore, we sought to investigate the preoperative factors contributing to postoperative BP outcome. Data for 96 PA patients who underwent unilateral adrenalectomy at our institution from January 2000 to February 2015 were retrospectively collected. Based on postoperative BP after a 12-month follow-up period, the patients were categorized into two groups: cured (C) (<140/90 mm Hg with no antihypertensive drug) and not cured (NC) (if not normotensive). Patient demographics, blood and urine data, data of loading tests and adrenal vein sampling were evaluated. In all, 46 patients were categorized as C and 50 patients as NC. There were significantly more males in the NC group. Age, body mass index (BMI), number of antihypertensive drugs prescribed, serum uric acid concentration and contralateral ratio (CR) after adrenocorticotropic hormone stimulation were significantly higher in the NC group. In the multivariate model, BMI and CR significantly correlated with resolution outcome. The optimal cutoff values were 23.3 kg m-2 for BMI and 0.5 for CR, and when both parameters were used as predictors, the most optimal cutoff values for BMI and CR were 25.2 kg m-2 and 0.1, respectively. BMI and CR significantly correlated with BP outcome after adrenalectomy. To our knowledge, this is the first report to show that in addition to BMI, CR is a factor in postoperative BP outcome and to determine the optimal cutoff values of BMI and CR and calculate their sensitivities and specificities.

Entities:  

Mesh:

Year:  2017        PMID: 28978983     DOI: 10.1038/hr.2017.78

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  42 in total

1.  The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension.

Authors:  Leonardo A Sechi; Cristiana Catena
Journal:  Am J Kidney Dis       Date:  2009-10       Impact factor: 8.860

2.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

3.  Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

Authors:  Gilberta Giacchetti; Vanessa Ronconi; Federica Turchi; Laura Agostinelli; Franco Mantero; Silvia Rilli; Marco Boscaro
Journal:  J Hypertens       Date:  2007-01       Impact factor: 4.844

4.  [Study on uric acid metabolism in patients with primary aldosteronism].

Authors:  M Namba; K Kikuchi; H Komura; S Suzuki; N Satoh; T Ohtomo; T Takada; S Marusaki; O Iimura
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1992-01-20

5.  [Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio].

Authors:  C Massien-Simon; C Battaglia; G Chatellier; T T Guyene; J M Duclos; P F Plouin
Journal:  Presse Med       Date:  1995-09-23       Impact factor: 1.228

6.  Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?

Authors:  C A Proye; E A Mulliez; B M Carnaille; M Lecomte-Houcke; M Decoulx; J L Wémeau; J Lefebvre; A Racadot; O Ernst; D Huglo; A Carré
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

7.  Abdominal obesity and hypertension: a double burden to the heart.

Authors:  Paweł Krzesiński; Adam Stańczyk; Katarzyna Piotrowicz; Grzegorz Gielerak; Beata Uziębło-Zyczkowska; Andrzej Skrobowski
Journal:  Hypertens Res       Date:  2016-01-21       Impact factor: 3.872

8.  Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients.

Authors:  C Catena; G Colussi; A Frangipane; A Russo; N D Verheyen; L A Sechi
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-07-03       Impact factor: 4.222

9.  Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.

Authors:  Tony C Pang; Chris Bambach; Judith C Monaghan; Stan B Sidhu; Alex Bune; Leigh W Delbridge; Mark S Sywak
Journal:  ANZ J Surg       Date:  2007-09       Impact factor: 1.872

10.  Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism.

Authors:  Shigehiro Karashima; Takashi Yoneda; Mitsuhiro Kometani; Masashi Ohe; Shunsuke Mori; Toshitaka Sawamura; Kenji Furukawa; Takashi Seta; Masakazu Yamagishi; Yoshiyu Takeda
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

View more
  2 in total

1.  Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism.

Authors:  Midori Yatabe; Kanako Bokuda; Kaoru Yamashita; Satoshi Morimoto; Junichi Yatabe; Yasufumi Seki; Daisuke Watanabe; Satoru Morita; Shuji Sakai; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-04-30       Impact factor: 3.872

2.  Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism.

Authors:  Ming-Jse Lee; Chiao-Yin Sun; Ching-Chu Lu; Yuan-Shian Chang; Heng-Chih Pan; Yen-Hung Lin; Vin-Cent Wu; Jeff S Chueh
Journal:  Ther Adv Chronic Dis       Date:  2021-02-12       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.